Fitch warns of Bayer downgrade on Monsanto bid | Fin24
  • Covid-19 Money Hub

    The hub will help answer your business and money questions during the coronavirus crisis.

  • Dudu Myeni

    The former SAA chair has been declared a delinquent director for her role at the national airline.

  • Cigarette Ban

    Govt says emerging research shows smoking leads to more severe cases of Covid-19.


Fitch warns of Bayer downgrade on Monsanto bid

May 25 2016 13:27

Frankfurt - The international credit rating agency Fitch said on Wednesday it would likely downgrade German chemicals and pharmaceuticals giant Bayer if its goes ahead with plans to buy US agrochemicals firm Monsanto for $62bn.

"Should the transaction go ahead at the conditions offered or with a revised higher offer, Fitch will likely downgrade Bayer's ... ratings by a minimum of two notches," Fitch said in a statement.

"The acquisition would cause an increase in leverage and business risk for the combined group," it added.

Rival agency Moody's had already announced on Tuesday that it was putting Bayer's ratings on "credit watch negative", or set for a possible downgrade.

Bayer, a household name thanks to its painkiller Aspirin, said this week that it is offering $122 per share in cash for Monsanto, or $62bn in all.

It would be the biggest takeover by a German group of a foreign company and create a new world leader in seeds, pesticides and genetically modified (GM) crops.

Monsanto has dismissed the offer as too low, but said it was willing to entertain further talks on a merger.

Bayer, for its part, said it was "confident that we can address any potential financing or regulatory matters related to the transaction" and it remained "committed to working together to complete this mutually compelling transaction."

monsanto  |  agribusiness  |  ratings agencies


Company Snapshot

Voting Booth

How has Covid-19 impacted your financial position?

Previous results · Suggest a vote